Drug Manufacturers
FDA hits Ozempic and Mounjaro counterfeit compounders with warning letters
Telix acquires RLS Radiopharmacies to expand US manufacturing presence
SBTi approves Piramal Pharma’s GHG reduction targets
Teva agrees to pay Baltimore City $80m for fuelling opioid epidemic
Combating Pharmaceutical Crime with On-Dose Authentication
Are PBMs to blame for high drug prices in the US?
Shortages improve for Lilly’s GLP-1 weight loss drugs, bumping sales forecast by $3bn
